•  
  •  
  •  
  •  

2025-12-23 09:47:05

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  AlmondzGlobalSecurities

Stock Report

  • Almondz Global Securities Ltd Q1 FY2025-26 consolidated net profit up at Rs. 6.90 crore
  • Almondz Global Securities Ltd's JV starts consturction of new plant
  • Almondz Global Securities Ltd approves investment
  • Almondz Global Securities Ltd's JV commissions enhanced capacity Ethanol Plant
  • Almondz Global Securities Ltd consolidated Q4FY23 PAT at Rs. 4.03 crore
  • Almondz Global Securities Ltd Q3 FY2023 consolidated PAT up at Rs. 4.06 crores
  • Almondz Global Securities Ltd posts Rs. 3.87 crores consolidated profit in Q2 FY2023
  • Almondz Global Securities Ltd consolidated Q4FY22 PAT at Rs. 1.77 crore
  • Almondz Global Securities Q3FY22 consolidated profit slides to Rs. 3.15 crores
  • Almondz Global Securities Ltd Q2FY22 consolidated net profit higher at Rs. 8.08 crore

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024